1163359

Lilly del Caribe, Inc — FEI 2619243

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations
360321 CFR 211.160(b)Scientifically sound laboratory controls